telavancin and Nephritis--Interstitial

telavancin has been researched along with Nephritis--Interstitial* in 1 studies

Other Studies

1 other study(ies) available for telavancin and Nephritis--Interstitial

ArticleYear
Telavancin-associated acute kidney injury
.
    Clinical nephrology, 2019, Volume: 91, Issue:3

    Telavancin is a lipoglycopeptide semi-synthetic derivative of vancomycin used for select infections caused by Gram-positive bacteria including

    Topics: Acute Kidney Injury; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Humans; Lipoglycopeptides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nephritis, Interstitial; Staphylococcal Infections

2019